Literature DB >> 32052091

Spontaneous adverse drug reaction reports on patients with cirrhosis: analysis of the nature, quantity and quality of the reports.

R A Weersink1,2, K Taxis3, E P van Puijenbroek3,4, S D Borgsteede5,6.   

Abstract

Entities:  

Year:  2020        PMID： 32052091     DOI： 10.1007/s00228-020-02845-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Hepatology       Date:  2015-09-15       Impact factor: 17.425

2.  The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.

Authors:  Carla Carnovale; Marta Gentili; Ida Fortino; Luca Merlino; Emilio Clementi; Sonia Radice
Journal:  Expert Opin Drug Saf       Date:  2016       Impact factor: 4.250

3.  Effects of sulindac and ibuprofen in patients with cirrhosis and ascites. An explanation for the renal-sparing effect of sulindac.

Authors:  G Laffi; G Daskalopoulos; I Kronborg; W Hsueh; P Gentilini; R D Zipser
Journal:  Gastroenterology       Date:  1986-01       Impact factor: 22.682

4.  Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis.

Authors:  Daniel B Hawcutt; Nicki-Jayne Russell; Hannah Maqsood; Koushan Kouranloo; Simon Gomberg; Catriona Waitt; Andrew Sharp; Andrew Riordan; Mark A Turner
Journal:  Br J Clin Pharmacol       Date:  2016-09-12       Impact factor: 4.335

5.  Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis.

Authors:  Carmen C Franz; Sabin Egger; Christa Born; Alexandra E Rätz Bravo; Stephan Krähenbühl
Journal:  Eur J Clin Pharmacol       Date:  2011-08-13       Impact factor: 2.953

Review 6.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

Review 7.  Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis.

Authors:  Rianne A Weersink; Margriet Bouma; David M Burger; Joost P H Drenth; S Froukje Harkes-Idzinga; Nicole G M Hunfeld; Herold J Metselaar; Margje H Monster-Simons; Katja Taxis; Sander D Borgsteede
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.